Publication | Closed Access

Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer

MedicineSerum ImmunoglobulinFarletuzumab PharmacokineticsPathologyGynecologyCancer GenomicsFcgrt Genomic StructureOncologyRadiation OncologyEndocrine-related CancerOvarian Cancer